Electroporation is a simple, rapid and efficient technique for introducing DNA, RNA, proteins and other bioactive molecules into cells and tissues. Electroporation involves the creation of transient, electrically induced membrane pores through which molecules pass into cytoplasmic and nuclear compartments. Because electroporation involves a physical process acting on cell membranes, it is effective with a wide range of cell types including bacterial, fungal, plant and animal cells. Electroporation is used to transiently or stably increase gene expression through transfection of plasmid‐borne gene expression cassettes or decrease gene expression using antisense RNA, small interfering RNA or short hairpin RNA systems. Recent advances have led to new techniques for tissue and organ electroporation in living animals. These techniques are increasingly used in clinical applications including gene therapy, cancer drug delivery and vaccination.
Key Concepts:
Gene transfer is fundamental to molecular genetic analysis in bacteria, plant and animal cells.
Electroporation introduces a wide variety of bioactive molecules into cells, including DNA, RNA, siRNA, proteins, drugs and dyes.
Electroporation creates transient membrane pores through which molecules pass into cytoplasmic and nuclear compartments.
Electroporation is used to transiently or stably upregulate or downregulate gene expression.
Electroporation is used to make stable genetic changes to chromosomes including gene knockout and knockin.
Electroporation of molecules into tissues and organs of living organisms is driving novel clinical applications including gene therapy, drug delivery and vaccination.
The cytotoxic effects of electroporation are being used in tissue ablation including direct killing of tumours.